#TxID physician at @NM_IDSteward focusing on donor-derived and viral infections
Chicago, IL
Joined June 2015
- Tweets3.1K
- Following0
- Followers1.3K
- Likes3.3K
Pinned Tweet
Sharing the link for slides I pulled together to update our institution. Please feel free to use as you need them. If you catch errors or mistakes, let me know @AST_IDCOP @PergamIC @PCH_SF dropbox.com/s/kb0n7hlzk63ezb…
More details about the chaos of the role out of distribution of #remdesivir. We need a fair and transparent process.
politico.com/news/2020/05/07…
Michael Ison retweeted
Hospitals and physicians around the country are sharply criticizing the federal government for the uneven and opaque way it is distributing its supply of the Covid-19 drug remdesivir. buff.ly/3drR8NB
Michael Ison retweeted
Remdesivir for covid-19: Doctors are flying blind in deciding which patients should get the drug - The Washington Post @IDSAInfo @RWalensky @MichaelIsonMD washingtonpost.com/opinions/…
Michael Ison retweeted
We just went past 10,000 decontaminated and safely reused N95 masks through the
@DukeHealth
- this has been a huge effort from environmental safety experts to keep us all safe!!
@TheDHVI
#PPEshortage
Michael Ison retweeted
The largest study of mortality risk w/ #COVID19 from >17 million UK patients, > 5,600 in-hospital deaths, a @medrxivpreprint today, by @bengoldacre and colleagues @LSHTM
medrxiv.org/content/10.1101/…
Note: age, diabetes, Asian & African ancestry, male, obesity, cancer, asthma (not HTN)
Need transparency at all levels about #Remdesivir allocation. If states are doing the allocation is there is single approach or variations being used? Is it really going to hospitals with the most patients in need? Transparency is needed NOW.
This Post is from an account that no longer exists. Learn more
The title of the article says it all “Trump officials' dysfunction harms delivery of coronavirus drug.” We are now 1 week since EUA and still no information on how remdesivir is being distributed. Our patients are suffering and dying due to this delay. axios.com/trump-coronavirus-…
Michael Ison retweeted
A team of @NorthwesternU researchers—including ISGMH Director @Mustanski and affiliate faculty member Richard D’Aquila—have developed a finger stick #antibody test to determine whether an individual has had prior exposure to the virus that causes #COVID19. buff.ly/3cfuHeq
Michael Ison retweeted
I signed. Please consider signing too
Michael Ison retweeted
Who’s gets remdesivir? After much confusion, Massachusetts government…so proud of our hospitals and MA DPH for ensuring equitable access #WeAreID @TuftsMedicalCtr @IDSAInfo @TuftsCIMAR @RWalensky bostonglobe.com/2020/05/07/n…
Michael Ison retweeted
How can a country that has required you to take your shoes off at airport security for a 2001 foiled attempt without a single person hurt ......
be the same one that has no systematic plan to address >73,000 Americans dead, >1.2 million confirmed cases?
Michael Ison retweeted
Interpreting Diagnostic Tests for SARS-CoV-2 ja.ma/2xNyr8a. A nice @JAMA_current VP on #SARSCoV2 testing.
Michael Ison retweeted
Maybe it is time to move on.
@NM_IDSteward @NU_IntMed
This Post is from an account that no longer exists. Learn more
Michael Ison retweeted
Proud of my friend @MichaelIsonMD for speaking out regarding the lack of transparency on Remdesivir Allocation: the public should be outraged
wsj.com/articles/health-care…
The Trump Administration is choosing which Americans will have access to remdesivir & who will not - but no one knows how these decisions are being made. If you aren't happy with this, call your Senator & Congressperson and ask for transparency in the distribution of remdesivir!
Michael Ison retweeted
Given increasing global travel, continued emergence of new infectious diseases, antibiotic-resistant organisms, and a growing population, the role that infectious diseases specialists will have in the health of everyone in society will only increase.
thelancet.com/journals/lanin…
